INFUSYSTEM HOLDINGS, INC (INFU) Share buybacks
- Total buybacks · last 12 months (USD): Value $7.83M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $7.83M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 7.83M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $7.83M | (m) | (m) |
| 2026-03-31 | $7.78M | (m) | (m) |
| 2025-12-31 | $9.87M | (m) | (m) |
| 2025-09-30 | $8.76M | (m) | (m) |
| 2025-06-30 | $7.29M | (m) | (m) |
| 2025-03-31 | $4.08M | (m) | (m) |
| 2024-12-31 | $1.18M | (m) | (m) |
| 2024-09-30 | $981.00K | (m) | (m) |
| 2024-06-30 | $283.00K | (m) | (m) |
| 2024-03-31 | $0.00 | (m) | (m) |
| 2023-12-31 | $153.00K | (m) | (m) |
| 2023-09-30 | $253.00K | (m) | (m) |
| 2023-06-30 | $1.26M | (m) | (m) |
| 2023-03-31 | $1.61M | (m) | (m) |
| 2022-12-31 | $5.46M | (m) | (m) |
| 2022-09-30 | $5.92M | (m) | (m) |
| 2022-06-30 | $4.92M | (m) | (m) |
| 2022-03-31 | $4.57M | (m) | (m) |
| 2021-12-31 | $560.00K | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) |
| 2019-12-31 | $0.00 | (m) | (m) |
| 2018-12-31 | $10.39M | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) |
| 2017-09-30 | $52.00K | (m) | (m) |
| 2017-06-30 | $70.00K | (m) | (m) |
| 2017-03-31 | $62.00K | (m) | (m) |
| 2016-12-31 | $75.00K | (m) | (m) |
| 2016-09-30 | $85.00K | (m) | (m) |
| 2016-06-30 | $164.00K | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) |
| 2015-12-31 | $179.00K | (m) | (m) |
| 2015-09-30 | $170.00K | (m) | (m) |
| 2015-06-30 | $149.00K | (m) | (m) |
| 2014-12-31 | $204.00K | (m) | (m) |
| 2014-09-30 | $179.00K | (m) | (m) |
| 2014-06-30 | $141.00K | (m) | (m) |
| 2013-12-31 | $79.00K | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) |
| 2012-12-31 | $144.00K | (m) | (m) |
| 2012-09-30 | $151.00K | (m) | (m) |
| 2012-06-30 | $147.00K | (m) | (m) |
| 2011-12-31 | $363.00K | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | $68.00K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |